Showing results (51-60 of 72) with videos related to
Sort By:
Pageof 8
Archiv Der Pharmazie|October 12, 2023
Identification of 3-(5-cyano-6-oxo-pyridin-2-yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activityMoataz A Shaldam, Ahmed F Khalil, Hadia Almahli, et al.RSC Advances|May 9, 2025
Targeted synthesis of a trimethoxyphenyltetrahydropyrimidine analogue designed as a DNA intercalator: in silico, multi-spectroscopic, thermodynamic, and in vitro approachesAhmed A Al-Karmalawy, Ayman Abo Elmaaty, Galal Magdy, et al.Microorganisms|November 27, 2021
Secnidazole Is a Promising Imidazole Mitigator of Serratia marcescens VirulenceAhdab N Khayyat, Hisham A Abbas, Maan T Khayat, et al.Microorganisms|May 28, 2022
Sodium Citrate Alleviates Virulence in Pseudomonas aeruginosaMaan T Khayat, Tarek S Ibrahim, Ahdab N Khayyat, et al.Journal of Medicinal Chemistry|December 20, 2023
Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical AssessmentsAhmed A Al-Karmalawy, Mai H A Mousa, Marwa Sharaky, et al.Bioorganic & Medicinal Chemistry Letters|October 17, 2020
New thiazolopyrimidine as anticancer agents: Synthesis, biological evaluation, DNA binding, molecular modeling and ADMET studySara T Al-Rashood, Shymaa S Elshahawy, Asmaa M El-Qaias, et al.RSC Medicinal Chemistry|July 19, 2024
Discovery of new 1,3-diphenylurea appended aryl pyridine derivatives as apoptosis inducers through c-MET and VEGFR-2 inhibition: design, synthesis, in vivo and in silico studiesHeba A Elsebaie, Mohamed S Nafie, Haytham O Tawfik, et al.Frontiers in Pharmacology|March 20, 2026
Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activityWagdy M Eldehna, Haytham O Tawfik, Denisa Veselá, et al.Frontiers in Pharmacology|June 30, 2026
Correction: Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activityWagdy M Eldehna, Haytham O Tawfik, Denisa Veselá, et al.Bioorganic Chemistry|March 29, 2026
Isatin-triazole/imidazole hybrids as dual CDK2/VEGFR2 inhibitors with potent anti-cancer activity: design, synthesis, and biological evaluationsZainab M Elsayed, Marwa Balaha, Haytham O Tawfik, et al.Pageof 8